News

Delve into the latest advancements in Sickle Cell Disease therapies with DelveInsight’s comprehensive report. Covering FDA, EMA, and PDMA approvals, clinical trials, mechanisms, and key companies like Bellicum Pharmaceuticals, Novartis, …

Patients with sickle cell disease (SCD) often grapple with diminished quality of life and a reduced life expectancy. The primary curative treatment, allotransplantation, carries risks, including transplant-related mortality. Gene therapy, …

In the transformative landscape of healthcare, 2023 emerged as a pivotal year for artificial intelligence (AI). With breakthroughs impacting both medical practices and patient experiences, AI became an integral part …

The Food and Drug Administration (FDA) has granted approval for a groundbreaking treatment for sickle cell disease, a debilitating condition affecting over 100,000 Americans, primarily from the Black community. Developed …

AstraZeneca, the pharmaceutical company renowned for developing one of the COVID-19 vaccines, has entered into a partnership with Absci, a U.S.-based artificial intelligence (AI) biologics firm. The collaboration involves an …

AB Science SA has announced that its masitinib in sickle cell disease is among the 19 projects to be funded under the “Hospital-University Research in Health” program. This program, part …

The global Artificial Intelligence (AI) in Animal Health market, as highlighted in the report released on November 20, 2023, has experienced significant growth, reaching a valuation of USD 901.81 million …

Sickle cell disease, affecting over 100,000 Americans, particularly impacts one in 365 African American babies born today. Danielle Lee, diagnosed before birth, endured unimaginable pain due to the genetic blood …

Jasmine Smith, the CEO of Rejuve.AI, a Web3-based wellness app, emphasized in an interview with Cointelegraph that decentralized and AI-powered platforms in health research are not designed to replace healthcare …